Form D · Biotechnology

RenovoRx, Inc.

Mountain View, CA · CIK 0001574094

Offering snapshot reported Apr 9, 2026 · SEC filing

Reported sold
$10M
Offering amount: $10M
Investors reported
16
Form D · investor count
Minimum accepted
$10K
Reported outside-investor minimum
First sale
Mar 20, 2026
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 9, 2026Initial$9,999,929No comparison16SEC filing
Apr 22, 2024Initial$11,136,557No comparison172SEC filing
Feb 9, 2024Initial$6,111,695No comparison92SEC filing
Jun 19, 2018Initial$8,309,774No comparison21SEC filing
Jan 5, 2016Initial$2,099,999No comparison18SEC filing
Dec 23, 2013Initial$1,140,000No comparison11SEC filing
Apr 10, 2013Initial$660,000No comparison8SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$550K
Finders' fees
$0
Form D file number
021-579681
The offering is closed.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
T.R. WINSTON & COMPANY, LLC10571

Source: Form D, filed Apr 9, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Ramtin Agah Executive
Ramtin Agah, M.D. Director
Shaun R. Bagai Director, Executive
Joost De Schutter Executive
Leesa Gentry Executive
Klaus Hambuechen Director
Ronald B. Kocak Executive
Ron Kocak Executive
Kirsten Angela Macfarlane Director
Laurence J. Marton Director
Laurence J. Marton, M.D. Director
Kamran Najmabadi Executive
Angela Gill Nelms Executive
Frank Rahmani Executive
Una S. Ryan Director
Una S, Ryan, Ph D Director
Una S. Ryan, Ph.D. Director
Robert J. Spiegel Director
Mark Voll Executive
Marta Gaia Zanchi, Ph D Director, Executive
Marta Gaia Zanchi, Ph.D. Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
2570 W El Camino Real, Suite 320
Mountain View, CA, 94040